form8k.htm
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
Date
of Report: April 21, 2009
(Date
of earliest event reported)
MedCom
USA, Incorporated
(Exact
name of registrant as specified in its charter)
|
Delaware
|
0-25474
|
65-0287558
|
|
(State
or other jurisdiction of incorporation or organization)
|
(Commission
File Number)
|
(I.R.S.
Employer Identification
Number)
|
Suite
140
7303
E. Earll Dr.
Scottsdale,
AZ 85253
(Address
of principal executive offices, including zip code)
(877)
763-3729
(Registrant's
telephone number, including area code)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
¨ Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
¨ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
Item
5.02 Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
On April
21, 2009, Pamela Thompson resigned as Chief Financial Officer of MedCom USA,
Incorporated. Her resignation was effective immediately.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
|
MedCom
USA, Incorporated
|
|
|
|
|
|
|
By:
|
/s/
William Bednarski
|
|
|
|
William
Bednarski
|
|
|
|
President
|
Date: April
27, 2009